Tuesday, February 7, 2017

(LML) Silent neuritis. Nerve damage. Disability and deformity. Prevention and management.

Leprosy Mailing List – February 8,  2017

Ref.:    (LML) Silent neuritis. Nerve damage. Disability and deformity. Prevention and management.

From:  Grace Warren, Sidney, Australia


 

Dear Pieter.,

Thank you for publishing the marvellous article by  Linda Lehman (LML, February 5, 2017) on the use of MFN for testing nerve function in Leprosy.

Congratulations too to Brazil for making these seas available in all areas (I assume from her comments) and hopefully they are used correctly for as she points out their use needs to be well taught.

I have never visited S. American let alone worked in Brazil but I am experienced in Asian countries and some African, and I know that the MFN sets are certainly not available. Most of the countries in which I have worked could not afford for the workers to go out doing the villagers and the contacts.

Is there any way of gaining global financial assistance  to enable such a useful tool? In the meantime can we train the workers to use what they have got for in many countries very few workers really do  touch tests correctly and make them helpful in assessing the activity of the disease and its progress.

She has set out very well the pros and cons of their use and I would like to see them used more, which means they must be more easily available.

Yours sincerely,

Grace  Warren

Previously adviser in Leprosy and rehabilitation surgery for The Leprosy Mission in Asia


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com




Avast logo

This email has been checked for viruses by Avast antivirus software.
www.avast.com


No comments: